Shopping Cart 0
Cart Subtotal
USD 0

Dyadic International Inc (DYAI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Dyadic International Inc (Dyadic) is a biotechnology company that develops, discovers, manufactures, and commercializes protein-based drugs. The company utilizes its patented and proprietary technology Myceliopthora thermophila expression systems to conduct research and produce industrial enzymes. It works in partnership with pharmaceutical company to develop imperative non-glycosylated therapeutic products such as ranibizumab and insulin with the help of C1 technology. The company serves bioenergy, biochemical, biopharmaceutical, and industrial enzyme industries. It has its operations the US and the Netherlands. Dyadic is headquartered in Jupiter, Florida, the US.

Dyadic International Inc (DYAI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Dyadic International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Dyadic International Inc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Dyadic International to Enter into Research Agreement with Sanofi-Aventis 10

Dyadic International Enters into Research Agreement with Mitsubishi Tanabe Pharma 11

Dyadic International Enters into R&D Agreement with Israel Institute for Biological Research 12

Dyadic International Enters into R&D Agreement with BDI Holdings 13

Dyadic International Enters into Co-Development Agreement for C1 Technology 14

Licensing Agreements 15

BASF Enters Into Licensing Agreement With Dyadic International For C1 Technology 15

Dyadic International Inc-Key Competitors 16

Dyadic International Inc-Key Employees 17

Dyadic International Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Financial Announcements 19

Aug 09, 2018: Dyadic International reports second quarter 2018 financial results 19

May 10, 2018: Dyadic International Reports First Quarter 2018 Financial Results 21

Mar 27, 2018: Dyadic International Announces 2017 Year End Results and Recent Developments 23

Nov 09, 2017: Dyadic International Reports Third Quarter 2017 Financial Results 25

Aug 10, 2017: Dyadic International Reports Second Quarter 2017 Financial Results 27

May 11, 2017: Dyadic International Reports First Quarter 2017 Financial Results 29

Mar 15, 2017: Dyadic International Reports 2016 Financial Results 31

Corporate Communications 33

Mar 15, 2018: Dyadic International Appoints Chief Accounting Officer 33

Jan 03, 2018: Dyadic International Appoints New Board Member 34

Apr 06, 2017: Dyadic Announces Director Resignation 35

Other Significant Developments 36

Jun 05, 2018: Dyadic to Develop Biosimilars Using CHO-Challenging Expression System 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Dyadic International Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Dyadic International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Dyadic International Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Dyadic International to Enter into Research Agreement with Sanofi-Aventis 10

Dyadic International Enters into Research Agreement with Mitsubishi Tanabe Pharma 11

Dyadic International Enters into R&D Agreement with Israel Institute for Biological Research 12

Dyadic International Enters into R&D Agreement with BDI Holdings 13

Dyadic International Enters into Co-Development Agreement for C1 Technology 14

BASF Enters Into Licensing Agreement With Dyadic International For C1 Technology 15

Dyadic International Inc, Key Competitors 16

Dyadic International Inc, Key Employees 17

Dyadic International Inc, Subsidiaries 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Dyadic International Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Dyadic International Inc (Dyadic) is a biotechnology company that develops, discovers, manufactures, and commercializes protein-based drugs. The company utilizes its patented and proprietary technology Myceliopthora thermophila expression systems to conduct research and produce industrial enzymes. It works in partnership with pharmaceutical company to develop imperative non-glycosylated therapeutic products such as ranibizumab and insulin with the help of C1 technology. The company serves bioenergy, biochemical, biopharmaceutical, and industrial enzyme industries. It has its operations the US and the Netherlands. Dyadic is headquartered in Jupiter, Florida, the US.

Dyadic International Inc (DYAI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Dyadic International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Dyadic International Inc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Dyadic International to Enter into Research Agreement with Sanofi-Aventis 10

Dyadic International Enters into Research Agreement with Mitsubishi Tanabe Pharma 11

Dyadic International Enters into R&D Agreement with Israel Institute for Biological Research 12

Dyadic International Enters into R&D Agreement with BDI Holdings 13

Dyadic International Enters into Co-Development Agreement for C1 Technology 14

Licensing Agreements 15

BASF Enters Into Licensing Agreement With Dyadic International For C1 Technology 15

Dyadic International Inc-Key Competitors 16

Dyadic International Inc-Key Employees 17

Dyadic International Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Financial Announcements 19

Aug 09, 2018: Dyadic International reports second quarter 2018 financial results 19

May 10, 2018: Dyadic International Reports First Quarter 2018 Financial Results 21

Mar 27, 2018: Dyadic International Announces 2017 Year End Results and Recent Developments 23

Nov 09, 2017: Dyadic International Reports Third Quarter 2017 Financial Results 25

Aug 10, 2017: Dyadic International Reports Second Quarter 2017 Financial Results 27

May 11, 2017: Dyadic International Reports First Quarter 2017 Financial Results 29

Mar 15, 2017: Dyadic International Reports 2016 Financial Results 31

Corporate Communications 33

Mar 15, 2018: Dyadic International Appoints Chief Accounting Officer 33

Jan 03, 2018: Dyadic International Appoints New Board Member 34

Apr 06, 2017: Dyadic Announces Director Resignation 35

Other Significant Developments 36

Jun 05, 2018: Dyadic to Develop Biosimilars Using CHO-Challenging Expression System 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Dyadic International Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Dyadic International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Dyadic International Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Dyadic International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Dyadic International to Enter into Research Agreement with Sanofi-Aventis 10

Dyadic International Enters into Research Agreement with Mitsubishi Tanabe Pharma 11

Dyadic International Enters into R&D Agreement with Israel Institute for Biological Research 12

Dyadic International Enters into R&D Agreement with BDI Holdings 13

Dyadic International Enters into Co-Development Agreement for C1 Technology 14

BASF Enters Into Licensing Agreement With Dyadic International For C1 Technology 15

Dyadic International Inc, Key Competitors 16

Dyadic International Inc, Key Employees 17

Dyadic International Inc, Subsidiaries 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Dyadic International Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.